A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL

I6F-MC-JJCB -

The main purpose of this study is to evaluate the safety of the study drug known as LY3039478 in combination with dexamethasone in participants with T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma (T-ALL/T-LBL)

Trial Summary

Age Range
≥2 years
Conditions the trial is for
Acute Lymphoblastic Leukemia, T-cell Lymphoblastic Lymphoma
What the trial is testing?
Dexamethasone, LY3039478
Could I receive a Placebo?
Yes
Enrollment Goal
36
Trial Dates
Oct 1, 2015 - Jan 15, 2018
How long will I be in the trial?
Your participation could last up to 16 weeks depending on how you and your tumor respond.
Trial Phase
II

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.